Surgery Partners, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Surgery Partners, Inc. due to significant losses following the company's disappointing financial results for Q4 and full year 2025 [1][3][4] Financial Performance - Surgery Partners reported full-year 2025 revenue of approximately $3.3 billion and Adjusted EBITDA of $526.2 million [3] - The company acknowledged that its fourth quarter results did not meet expectations, leading to a sharp decline in its share price [3] Investigation Details - The investigation by Johnson Fistel focuses on whether Surgery Partners complied with federal securities laws in light of the reported financial results [1][4] - Investors who suffered losses from their investment in Surgery Partners stock are encouraged to join the investigation [2][4] Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States, specializing in securities class action lawsuits [5] - The firm has been recognized among the Top 10 Plaintiff Law Firms in 2024, having recovered approximately $90.7 million for clients in cases where it served as lead or co-lead counsel [6]